After graduating (B.Sc) with First class from University of Delhi, I was selected to M.Sc Industrial Biotechnology programme of Sardar Patel University Gujarat through All India combined biotechnology entrance exam conducted by Department of Biotechnology (Govt. of India) and Jawahar Lal Nehru University Delhi. Along with completion of my post graduate study with First class with distinction as a Topper, I qualified GATE (97.2 percentile AIR-296), DBT JRF, ICMR JRF exam, UGC-CSIR NET exam of National repute. Later I qualified All India SCMM-JNU entrance exam for PhD for four seats and topped it. My PhD work was awarded BEST POSTER AWARD at SBC-2010 Conference held at IISC Banglore. After completing my PhD, I worked as Assistant Professor/ Research Scientist -1 at Sardar Patel University Gujarat. Currently I am working as Asistant Professor in Biotechnology Department of Lovely Professional University, India.
Worldwide there is an issue of irreproducibility in life science research. Each year Trillions of dollars are invested in finding solutions of various diseases worldwide. Scientists in the United States spend $28 billion each year on basic biomedical research that cannot be repeated successfully. 53% of all preclinical studies have errors that mean they are not reproducible. Due to this therapies are being delayed, research budgets face increasing pressure, and drug development and treatment costs are rising. I wish to inform that “ Human Genome Project” is not yet complete even though its first draft was announced 15 years ago. Many scientific communities have discussed various scientific and non-scientific reasons behind irreproducibility issuer. A recent report by John Arrowsmith revealed that the Phase II success rate for new development projects has decreased by 10% in the last few years. It will definitely increase the cost of new drugs in the future. It will also decrease the trust of the public Government and funding agencies in scientific activities. Few scientists had reported technical flaws of various molecular techniques but still they have not reported any fundamental reason behind those errors. We first time want to explore the role of a neglected DNA structure (Parallel stranded DNA) in various molecular techniques.
Therapeutic delivery of mir-200c enhances radiosensitivity in lung cancer